ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,211, issued on Sept. 8, was assigned to University of Kentucky Research Foundation (Lexington, Ky.).
"Gold(III) compounds and cancer cell-selective modulation of mitochondrial respiration and metabolism" was invented by Samuel Awuah (Lexington, Ky.) and Randall Tyler Mertens (Madisonville, Ky.).
According to the abstract* released by the U.S. Patent & Trademark Office: "A compound of formula (I) is provided. Useful compounds and compositions, and methods of making and methods of using such compounds and compositions. The subject matter also relates to methods of treating cancer using compounds and compositions provided."
The patent was filed on July 29, 2021, under Application N...